This HTML5 document contains 103 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://dx.doi.org/10.1097/
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q47671273

rdf:type

wikibase:Item

schema:description

article scientific vitenskapelig artikkel artigo científico vetenskaplig artikel bài báo khoa học 1998年學術文章 1998年學術文章 artículo científico publicado en 1998 articolo scientifico мақолаи илмӣ mokslinis straipsnis מאמר מדעי наукова стаття, опублікована в серпні 1998 article scientifique (publié 1998) article científic 1998年学术文章 επιστημονικό άρθρο artigo científico (publicado na 1998) artigo científico (publicado na 1998) vitskapeleg artikkel 1998年學術文章 vedecký článok 1998 nî lūn-bûn научни чланак научная статья 1998年學術文章 tudományos cikk سائنسی مضمون 1998年学术文章 บทความทางวิทยาศาสตร์ artículu científicu videnskabelig artikel (udgivet 1998) مقالة علمية 1998年学术文章 artikulong pang-agham 1998年の論文 სამეცნიერო სტატია naučni članak vědecký článek bilimsel makale 1998年学术文章 tieteellinen artikkeli scientific article научни чланак articol științific scienca artikolo teaduslik artikkel مقالهٔ علمی научна статия 1998年學術文章 artykuł naukowy 1998年学术文章 1998年學術文章 1998년 논문 мақолаи илмӣ wetenschappelijk artikel ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ գիտական հոդված wissenschaftlicher Artikel artikull shkencor

p:P577

wds:Q47671273-ED769ACE-8B25-4CB1-B8F8-8DBAB42648F5

wdt:P577

1998-08-01T00:00:00Z

p:P2093

wds:Q47671273-6AD44630-0012-4751-A66E-479CAE812C07 wds:Q47671273-CCC0D1FC-32DB-4B0E-95F5-3BB29079EBA3 wds:Q47671273-8FF472DC-5A83-4BCC-9494-31385BE8EAA3 wds:Q47671273-F3C18718-2A71-45B4-AFE7-8745A5CA52F7 wds:Q47671273-F8C09158-8653-460A-82C4-E414D644A4D6

wdt:P2093

Walker C Weaver CH Upton S Zhen B Schwartzberg L

rdfs:label

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy. A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.

skos:prefLabel

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy. A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.

schema:name

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy. A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.

p:P50

wds:Q47671273-C8693544-D5E2-49F3-BCB3-23D904BAB90D

wdt:P50

wd:Q75039324

p:P1476

wds:Q47671273-191DB825-4CB1-4428-AACB-2151A4CB4738

wdt:P1476

A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy.

p:P304

wds:Q47671273-8688FA14-812A-43B0-A021-6DF7968587D2

wdt:P304

408-412

p:P31

wds:Q47671273-E5C312E6-3789-42E2-A50A-9C4B8310C702

wdt:P31

wd:Q13442814

p:P921

wds:Q47671273-F7D2DC26-F7BB-4376-B403-C1501D090A62 wds:Q47671273-719865E1-E39B-49A2-A874-EC3F9296D37B

wdt:P921

wd:Q418817 wd:Q412415

p:P698

wds:Q47671273-FA0EE52B-3E9F-475F-91C0-90E57F67E0B5

wdtn:P698

n12:9708644

wdt:P698

9708644

p:P1433

wds:Q47671273-FF6152BC-BB19-458B-B860-BC15F009E473

wdt:P1433

wd:Q2886177

p:P433

wds:Q47671273-164D3AF1-1D50-4E35-9C90-0D1D580095C9

p:P478

wds:Q47671273-266216D7-C8A7-4AA8-A38E-2E9B89F4FB85

wdt:P433

4

wdt:P478

21

p:P356

wds:Q47671273-8ACDFD34-CCAF-4FD4-AEA9-6DA5041032C1

wdtn:P356

n9:00000421-199808000-00019

wdt:P356

10.1097/00000421-199808000-00019